Core Scientific, Inc.
NASDAQ:CORZSoftware - Infrastructure
+$0.30 today
- Market cap
- $4.35B
- Beta
- 5.48
- P/E (TTM)
- -7.5
- EPS (TTM)
- -$3.77
Volume 11.93M
Average 13.68M
CORZ Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Core Scientific, Inc.NASDAQ: CORZ
Research & Development · Q3 FY2026 · quarter ended Sep 2026
Research & development remains negative
Q3 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, down 2.3 pp from a year earlier.
- Research & development increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- -100.0%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | -100.0% |
| FY2024 | 2024-12-31 | 11.83M | +64.7% |
| FY2023 | 2023-12-31 | 7.18M | -73.4% |
| FY2022 | 2022-12-31 | 26.96M | +251.3% |
| FY2021 | 2021-12-31 | 7.67M | — |
Research & Development vs competitors
How CORZ compares with its peers on the latest reported figures
- CORZ's LTM Sep 2026 research & development of $0 is the highest of the 5 companies compared; the peer median is $0.
- Its year-over-year change of -100.0% is the highest of 2, against a peer median of -126.7%.
- Research & development amounts to 0.0% of revenue for CORZ, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $0 | -100.0% | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Aug 2026 | $0 | — | — | 0.0% | |
ABTCAmerican Bitcoin Corp | LTM Mar 2026 | $0 | — | — | 0.0% |
DTCXDatacentrex, Inc. | LTM Mar 2026 | -$75.46K | -126.7% | — | 0.8% |
| Peer median (excluding CORZ) | $0 | -126.7% | — | 0.0% | |
Competitors are the stored peer set for CORZ. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 544.48M | 640.31M | 502.4M | 510.67M | 319.02M |
| Cost of Revenue | 305.62M | 631.91M | 378.94M | 389.6M | 281.12M |
| Gross Profit | 238.86M | 8.4M | 123.46M | 121.07M | 37.9M |
| Gross Margin | 43.9% | 1.3% | 24.6% | 23.7% | 11.9% |
| Research & Development | 7.67M | 26.96M | 7.18M | 11.83M | 0 |
| Selling, General & Admin | 64.55M | 226.01M | 100.93M | 120.42M | 182.6M |
| Operating Expenses | 72.22M | 2.12B | 114.5M | 140.27M | 262.45M |
| Depreciation & Amortization | 33.36M | 226.09M | 96.45M | 120.12M | 80.18M |
| EBITDA | 140.79M | (1.84B) | (63.12M) | (1.16B) | (207.85M) |
| EBITDA Margin | 25.9% | -287.4% | -12.6% | -226.6% | -65.2% |
| Operating Income | 166.64M | (2.11B) | 8.96M | (19.2M) | (224.55M) |
| Operating Margin | 30.6% | -329.5% | 1.8% | -3.8% | -70.4% |
| Interest Income | 0 | 0 | 0 | 0 | 3.28M |
| Interest Expense | 44.35M | 96.83M | 86.24M | 37.07M | 0 |
| Other Income / Expenses | (103.57M) | (53.86M) | (254.77M) | (1.29B) | (63.48M) |
| Income Before Tax | 63.08M | (2.16B) | (245.8M) | (1.31B) | (288.03M) |
| Pre-Tax Margin | 11.6% | -337.9% | -48.9% | -257.3% | -90.3% |
| Income Tax Expense | 15.76M | (17.09M) | 683K | 859K | 583K |
| Net Income | 47.31M | (2.15B) | (246.49M) | (1.32B) | (288.62M) |
| Net Margin | 8.7% | -335.2% | -49.1% | -257.5% | -90.5% |
| EPS (Basic) | 0.23 | (6.30) | (0.65) | (5.14) | (0.88) |
| EPS (Diluted) | 0.20 | (6.30) | (0.65) | (5.14) | (0.88) |
| Weighted Avg Shares | 207.26M | 340.65M | 379.86M | 255.83M | 318.07M |
| Weighted Avg Shares (Diluted) | 233.31M | 340.65M | 379.86M | 255.83M | 318.07M |
Core Scientific, Inc.
NASDAQ:CORZ
Intrinsic Alpha fair value
Locked
Current Price
$13.51
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.